Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 19
EDAP products registered in France
By
AuntMinnieEurope.com staff writers
EDAP TMS has announced that its Sonolith lithotripter products, including Sonolith i-sys and Sonolith i-move, have been exclusively registered by UGAP, the French Public Purchasing Agency.
December 6, 2010
Chemo + radiation may save cancerous bladders
By
Reuters Health
NEW YORK (Reuters Health) - Treatment with chemotherapy plus radiation therapy is a viable alternative to radical surgery in some patients with muscle invasive bladder cancer, according to presentation at Monday's plenary session of the American Society for Radiation Oncology annual meeting.
November 3, 2010
Pre-op RT improves rectal cancer outcomes
By
Reuters Health
NEW YORK (Reuters Health) - A short course of radiation therapy (RT) prior to total mesorectal excision for rectal cancer cuts the long-term risk of recurrence in half, according to data presented at this week's American Society for Radiation Oncology (ASTRO) meeting in San Diego.
November 2, 2010
High-intensity focused US for prostate cancer: no good evidence
By
Reuters Health
NEW YORK (Reuters Health) - There is no good evidence to support the use of high-intensity focused ultrasound in prostate cancer, although the treatment was developed nearly two decades ago.
October 28, 2010
Low-risk prostate cancer patients choose surveillance in U.K.
By
Cynthia E. Keen
Thousands of men in the U.K. diagnosed with low-risk localized prostate cancer are delaying aggressive treatment, according to a new study in the October issue of
BJU International
. Instead, they are opting for active surveillance that includes monitoring and testing of prostate-specific antigen levels.
October 20, 2010
Nucletron signs license agreements
By
AuntMinnieEurope.com staff writers
Radiation oncology firm Nucletron has signed license agreements with MedCom and Pi Medical for Oncentra Seeds, the next-generation seeds treatment planning module of Oncentra Prostate.
September 27, 2010
Algorithm can't tell which kids need voiding cystourethrogram: study
By
Reuters Health
NEW YORK (Reuters Health), Aug 12 - When Finnish researchers were looking for a way to identify kids with urinary tract infection who needed voiding cystourethrography, they tested a clinical rule published 10 years ago -- but it didn't work in their patients.
August 11, 2010
High-intensity focused ultrasound effective for localized prostate cancer
By
Reuters Health
NEW YORK (Reuters Health), Jul 21 - In men with localized prostate cancer, high-intensity focused ultrasound (HIFU) can achieve results comparable to those expected with external-beam radiation therapy, a French group reports.
July 20, 2010
Hypofractionated radiotherapy outcomes good in prostate CA: study
By
Reuters Health
NEW YORK (Reuters Health), Jun 30 - Late prostate cancer morbidity and biochemical failure rates appear similar with hypofractionated or conventional 3D radiation therapy, according to a report from Italy.
June 29, 2010
Salvage radiation effective after ultrasound treatment of localized prostate cancer
By
Reuters Health
NEW YORK (Reuters Health), June 30 - Salvage radiation therapy effectively treats local failure following high-intensity focused ultrasound treatment for localized prostate cancer, according to a study published online on June 11 in
European Urology
.
June 29, 2010
Local treatment boosts androgen-deprivation therapy in prostate cancer
By
Reuters Health
NEW YORK (Reuters Health), Jun 16 - For locally advanced and metastatic prostate cancer, the best timing and duration of androgen-deprivation therapy is unclear. Now, a systematic review suggests immediate and sustained treatment leads to best results, especially when combined with local treatment.
June 15, 2010
Bone metastasis, skeletal events predict poor prostate CA prognosis
By
Reuters Health
NEW YORK (Reuters Health), Jun 11 - Among men with prostate cancer, those with bone lesions and skeletal events have the worst survival, with fewer than 1% alive at five years, a large Danish study shows.
June 10, 2010
Previous Page
Page 19 of 22
Next Page